SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 2 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,000 | +400.0% | 9,011 | +260.4% | 0.00% | – |
| Q1 2016 | $1,000 | -97.8% | 2,500 | -95.0% | 0.00% | – |
| Q4 2015 | $45,000 | +221.4% | 49,814 | +194.8% | 0.00% | – |
| Q3 2015 | $14,000 | -90.2% | 16,900 | -64.3% | 0.00% | – |
| Q2 2015 | $143,000 | -82.1% | 47,353 | -85.5% | 0.00% | -100.0% |
| Q1 2015 | $800,000 | -39.8% | 326,748 | -37.3% | 0.00% | 0.0% |
| Q4 2014 | $1,330,000 | – | 521,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
| RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
| GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
| Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
| DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
| Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
| Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
| EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |